Skip to main content
. 2021 Sep 27;9(10):1089. doi: 10.3390/vaccines9101089

Table 2.

Reactogenicity groups relevant for the selection process separated by sex.

Group 1 Group 2 Group 3 Group 4 Group 5
Adverse Reactions after
1st/2nd Vaccination
Severe
Severe
Moderate
Severe
Severe
Moderate
No or Minor
Severe
No or Minor
No or Minor
sex male female male female male female male female male female
all responders
(n = 735)
2 19 7 59 0 6 31 131 76 149
participants
included in analysis (n = 76)
1 13 5 5 - - 14 - 20 18